Himalaya Nutravedics India is an SME IPO scheduled to open on 22 Sept 2026 and close on 24 Sept 2026, priced at ₹100 – ₹106 per share, minimum lot 1,200 shares (~₹2,54,400 for retail). Proposed listing on BSE SME on 29 Sept 2026.
About Himalaya Nutravedics India
Himalaya Nutravedics manufactures and supplies a range of Ayurvedic and nutraceutical products across multiple dosage forms, including softgel capsules, hardgel capsules, tablets, liquid orals, medicated oils, and protein powders. The company operates through a single integrated manufacturing facility located in Hyderabad, Telangana. Its product portfolio covers therapeutic categories such as pain management, infertility, women’s wellness, gut health, neurological support, and general wellness. The business generates revenue primarily from the sale of Ayurvedic formulations, alongside nutraceutical offerings. The company operates mainly through a business-to-business model, supplying products to stockists, distributors, and third-party contract manufacturing clients across various states in India. It also undertakes custom contract manufacturing for corporate clients under their own brand names utilizing its manufacturing infrastructure. Furthermore, the company is expanding its market presence into direct-to-consumer sales channels through digital platforms, e-commerce marketplaces, and quick commerce delivery services.
Himalaya Nutravedics India IPO Details
| IPO Type | SME |
| Price Band | ₹100 – ₹106 per share |
| Lot Size | 1,200 shares · ~₹2,54,400 for retail |
| Grey Market Premium (GMP) | Not available yet |
| Total Issue Size | ₹26.50 crore |
| Listing At | BSE SME |
Himalaya Nutravedics India IPO Important Dates
| Event | Date |
|---|---|
| IPO Open Date | 22 Sept 2026 |
| IPO Close Date | 24 Sept 2026 |
| Basis of Allotment | 25 Sept 2026 |
| Refund / UPI Mandate Release | 26 Sept 2026 |
| Credit of Shares to Demat | 26 Sept 2026 |
| Listing Date | 29 Sept 2026 |
Himalaya Nutravedics India IPO Lot Size & Investment
| Category | Lots | Shares | Amount |
|---|---|---|---|
| Retail | 2 | 2,400 | ₹2,54,400 |
| HNI | 3 – 7 | 3,600 – 8,400 | ₹3,81,600 – ₹8,90,400 |
Himalaya Nutravedics India IPO GMP (Grey Market Premium)
The latest grey market premium for Himalaya Nutravedics India is Not available yet. GMP is an unofficial, over-the-counter figure that can change through the day and is not endorsed by SEBI or the exchanges.
Himalaya Nutravedics India — Strengths
- Integrated manufacturing facility capable of producing multiple dosage forms.
- Diverse Ayurvedic and nutraceutical product portfolio across key therapeutic areas.
- Established B2B distribution network with presence across 17 Indian states.
- Track record of strong revenue and net profit growth over recent fiscal years.
- In-house quality assurance and control capabilities across production processes.
Himalaya Nutravedics India — Risks
- High revenue reliance on Ayurvedic products, accounting for over 90% of sales.
- Significant revenue concentration from top 10 customers representing over 80% of revenue.
- Operations from a single leased manufacturing facility located in Hyderabad, Telangana.
- Pending trademark opposition proceedings for corporate logos and mark applications.
- History of negative cash flows from operating activities due to working capital needs.
Himalaya Nutravedics India IPO Prospectus
Read the offer document: Himalaya Nutravedics India DRHP / RHP (PDF).
More on Himalaya Nutravedics India IPO
- Himalaya Nutravedics India IPO — live GMP, subscription & allotment status
- Himalaya Nutravedics India IPO listing gain calculator
- All SME IPOs
- Full IPO list with GMP
Allotment and listing-gain details will be published here once available. This article is for information only and is not investment advice. Read the RHP and consider your own risk profile before investing.
Loading comments...